CRANBURY, N.J.--(BUSINESS WIRE)--Innophos Holdings, Inc. (NASDAQ:IPHS) announced today the appointment of Nicolas Meyrial as Vice President, Commercial—Nutrition. In this role, Meyrial will be responsible for Innophos’ Nutrition sales organization and will be integral in growing the Company’s presence and capabilities in the Food, Health, and Nutrition (FHN) markets. He will report to Innophos’ Chairman, President and Chief Executive Officer, Kim Ann Mink, Ph.D. and also become a member of the Company’s Executive Leadership Council.
Meyrial joins Innophos from LV Lomas where he served as Director for their Home and Personal Care business unit. Prior to that, he was with Frutarom Health & Nutrition as Vice President of Sales & Business Development where he led their Health and Nutrition business unit in North America. Before his tenure at Frutarom, Meyrial spent seven years with Naturex. Earlier in his career, he was with Samaro where he held roles of increasing responsibility, including Regional Head of Sales & Marketing.
Meyrial is an accomplished commercial leader with a notable track record in formulating innovative strategies, driving profitable revenue and creating growth within the nutrition and personal care markets. He has extensive international business experience, a talent for leading people and a successful background in building sustainable competitive advantage.
“We are thrilled to have Nicolas join the Innophos team,” said Kim Ann Mink, Ph.D. “Nicolas will help build on our forward momentum and play a pivotal role in executing on our strategic goals. He will lead our Nutrition sales team and collaborate across functions to develop innovative solutions that diversify our products, align with industry megatrends and better serve our customers. With his expertise and exceptional leadership skills, we are well on our way to becoming a market leading solutions provider to the FHN markets.”
“It is an exciting time to join Innophos and I look forward to working together with our sales, marketing and technology teams to expand the Company’s presence in the high-growth FHN markets,” commented Meyrial. “I am confident that my experience and industry knowledge will enable me to further strengthen customer relationships and develop a commercial strategy that drives profitability and supports the Company’s Vision 2022 goals.”
Meyrial obtained his Master of Science degree in Agro-Engineering with a major in Food and Beverage Industry Technologies from the Graduate School of Engineering – ISARA in Lyon, France. He later went on to complete an Executive MBA with emphasis on Corporate Finance from The Wharton School of Business of the University of Pennsylvania.
About the Company
Innophos is a leading international producer of specialty ingredient solutions that deliver far-reaching, versatile benefits for the food, health, nutrition and industrial markets. We leverage our expertise in the science and technology of blending and formulating phosphate, mineral, enzyme and botanical based ingredients to help our customers offer products that are tasty, healthy, nutritious and economical. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations across the United States, in Canada, Mexico and China. In 2017 Innophos acquired Novel Ingredients and NutraGenesis, further expanding its food, health and nutrition platform. For more information, please visit www.innophos.com. 'IPHS-G'
Safe Harbor for Forward-Looking and Cautionary Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. As such, final results could differ from estimates or expectations due to risks and uncertainties, including but not limited to: incomplete or preliminary information; changes in government regulations and policies; continued acceptance of Innophos' products and services in the marketplace; competitive factors; technological changes; Innophos' dependence upon suppliers; and other risks. For any of these factors, Innophos claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, as amended.